secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2026-06-02T12:51:39+00:00
Accession:  0001193125-26-252624
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences appoints Jeff Farrow and Dr. Reid Waldman to Board
------------------------------------------------------------------------

- Jeff Farrow appointed to Audit Committee as Chair and Nominating & Governance Committee as member.
- Dr. Reid Waldman appointed to Compensation Committee as Chair and Commercial Committee as member.
- Each new director receives pro-rated $40,000 annual retainer for FY 2026 plus committee cash compensation.
- Each receives a stock option for 47,250 shares vesting monthly over three years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/0001193125-26-252624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000119312526252624/achv-20260529.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-252624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer